Cardiovascular disease incidence
1 paper2 findings
Associations
2TyG-BMI
upin humans1RR 1.51
1 study
TyG-BMI
upin humans1RR 1.51
TyG-BMI raises the risk of cardiovascular disease incidence in humans (RR = 1.51, 95% CI: 1.36-1.67).
Humanshighest vs. lowest category
Frontiers in endocrinology17 Aug 2026
CTI
upin humans1RR 1.57
1 study
CTI
upin humans1RR 1.57
CTI raises the risk of cardiovascular disease incidence in humans (RR = 1.57, 95% CI: 1.33-1.85).
Humanshighest vs. lowest category
Frontiers in endocrinology17 Aug 2026
Latest
11 in 12 monthsJournal of Affective Disorders
Depressive symptom profiles and risk of cardiometabolic disease incidence
Cohort study of 1,858 peopleMajor depressive disorder
Journal of Lipid and Atherosclerosis
Cardiovascular Disease Incidence and Lipid-Lowering Medication Use in Korean Adults With Dyslipidemia: A Nationwide Population-Based Retrospective Cohort Study From 2010 to 2019
Cohort study in peopleDyslipidemia
Journal of the American Heart Association
Reproductive Characteristics, Postmenopausal Obesity, and Cardiovascular Disease Incidence in the Women's Health Initiative
Cohort study of 119,182 peopleCardiovascular disease
Research Square
A Dynamic Bayesian Network Model for Predicting Cardiovascular Disease Incidence in the Tehran Lipid and Glucose Study
Preprint: cohort study of 7,839 peopleCardiovascular disease
Journal of the American Heart Association
Association Between Rest-Activity Rhythm and Cardiovascular Disease, Cardiovascular Mortality, and All-Cause Mortality: A Systematic Review and Meta-Analysis
Meta-analysis of observational studiesCardiovascular disease
Circulation Population Health and Outcomes
Cardiovascular Disease Incidence and Risk Factor Contributions in Adults Aged 45 to 59 Years With Low 10-Year and High 30-Year Risk: Findings From REGARDS
Cohort study of 6,761 peopleCardiovascular disease
Frontiers in Endocrinology
Mortality and cardiovascular risk of triglyceride-glucose and derived indices in cardiovascular-kidney-metabolic syndrome stages 0-3: a dose-response meta-analysis
Meta-analysis of observational studiesCardiovascular-kidney-metabolic syndrome
European Heart Journal
Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk
Cohort study of 40,237,152 peopleCardiovascular disease
Frontiers in Endocrinology
Association between metabolic syndrome and mortality among breast cancer survivors: a prospective cohort study
Cohort study of 6,027 peopleMetabolic syndrome
Diabetologia
Incidence and independent risk factors for heart failure in a population-based cohort of 19,892 individuals with newly diagnosed diabetes
Cohort study of 19,892 peopleHeart failure